Cargando…

2240. Can Antibiotic Duration Be Reduced by the Sequential Use of Procalcitonin and Endotoxin in Patients with Sepsis? A Prospective Double-Blind Clinical Trial

BACKGROUND: Patients hospitalized with sepsis are commonly treated with antibiotics for 10–21 days. Evidence is lacking to support this duration. We hypothesize that the sequential measurement of procalcitonin [PCT] (host biomarker) and endotoxin activity assay [EAA] (microorganism biomarker) could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalil, Andre C, Florescu, Diana F, Shafer, Laura R, Van Schooneveld, Trevor C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810774/ http://dx.doi.org/10.1093/ofid/ofz360.1918

Ejemplares similares

Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008)

Procalcitonin – Assisted Antibiotic Strategy in Sepsis
por: Trásy, Domonkos, et al.
Publicado: (2017)

PROJECT ADMINISTRATION AGREEMENT KN2240/EN
por: THE EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH, CERN, et al.
Publicado: (2013)

The complex link between influenza and severe sepsis
por: Florescu, Diana F, et al.
Publicado: (2014)

Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates
por: Geraerds, A. J. L. M., et al.
Publicado: (2021)

Is cytomegalovirus reactivation increasing the mortality of patients with severe sepsis?
por: Kalil, Andre C, et al.
Publicado: (2011)

Severe sepsis: are PROWESS and PROWESS-SHOCK trials comparable? A clinical and statistical heterogeneity analysis
por: Kalil, Andre C, et al.
Publicado: (2013)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Vijayan, Ashitha L., et al.
Publicado: (2017)

2240: High-throughput phenotyping and the increased risk of OSA in Rosacia patients
por: Elkin, Peter, et al.
Publicado: (2018)

Serum procalcitonin in sepsis
por: Wiwanitkit, Viroj
Publicado: (2011)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Guiding Effect of Serum Procalcitonin (PCT) on the Antibiotic Application to Patients with Sepsis
por: LIU, Yu, et al.
Publicado: (2017)

2240. Characteristics of Lung Cancer Treatment in Recent ART-era HIV+ Patients
por: Kobayashi, Takaaki, et al.
Publicado: (2018)

PB2240: SILENT GLOBIN MUTATIONS. 10 YEARS REFERRALS FOR GENETIC COUNSELING.
por: Theodoridou, S., et al.
Publicado: (2022)

2240. Implementation of a Clinical Decision Support Panel for Urine Culture Ordering
por: Yarrington, Michael E, et al.
Publicado: (2022)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Correlation of endotoxin, procalcitonin and C-reactive peptide patterns with ICU admission
por: Otero, R, et al.
Publicado: (2008)

Serum procalcitonin level correlates with endotoxin activity in patients with septic shock
por: Adamik, B, et al.
Publicado: (2015)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Using procalcitonin to guide antimicrobial duration in sepsis: asking the same questions will not bring different answers
por: Salluh, Jorge IF, et al.
Publicado: (2014)

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: some research questions
por: Kahn, Robert E
Publicado: (2009)

Epidemiology of maxillofacial fractures in northwest China: an 11-year retrospective study of 2240 patients
por: Mao, Jingjing, et al.
Publicado: (2023)

Amalgamation of procalcitonin, C-reactive protein, and sequential organ failure scoring system in predicting sepsis survival
por: Hegazy, M. A., et al.
Publicado: (2014)

Procalcitonin as an adjunctive biomarker in sepsis
por: Sinha, Mahua, et al.
Publicado: (2011)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Significance of serum procalcitonin in sepsis
por: Sudhir, Uchil, et al.
Publicado: (2011)

Adherence to a procalcitonin-guided antibiotic treatment protocol in patients with severe sepsis and septic shock
por: Hohn, Andreas, et al.
Publicado: (2018)

Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study
por: Vishalashi, SM Gowri, et al.
Publicado: (2021)

Impact of adherence to procalcitonin antibiotic prescribing guideline recommendations for low procalcitonin levels on antibiotic use
por: Malley, Brian E., et al.
Publicado: (2023)

2240. Breaking Dogmas: A Single Center Evaluation of Empiric Vancomycin Use Among Intensive Care Unit Patients with Suspected Pneumonia, Bacteremia or Sepsis
por: Xie, Christina Y, et al.
Publicado: (2023)

Endotoxin assay with endotoxin scattering photometry is one of the diagnostic markers of sepsis
por: Kase, Y, et al.
Publicado: (2010)

Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome
por: Charles, Pierre Emmanuel, et al.
Publicado: (2009)

Response of letter to the editor on Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy
por: Saikant, R., et al.
Publicado: (2017)

Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study
por: Schuetz, Philipp, et al.
Publicado: (2017)

Rates of agreement of endotoxin, procalcitonin and lactate in septic and non-septic critically ill patients
por: Foster, D, et al.
Publicado: (2005)

Neonatal Procalcitonin Intervention Study (NeoPInS): Effect of Procalcitonin-guided decision making on Duration of antibiotic Therapy in suspected neonatal early-onset Sepsis: A multi-centre randomized superiority and non-inferiority Intervention Study
por: Stocker, Martin, et al.
Publicado: (2010)

Optimization of antibiotic therapy by procalcitonin
por: Popov, D, et al.
Publicado: (2009)

86. Use of a Novel Clinical Decision Support Tool for Pharmacist-Led Antimicrobial Stewardship in Patients with Normal Procalcitonin
por: Watkins, Andrew B, et al.
Publicado: (2020)

Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial
por: Hochreiter, Marcel, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0aeh0is7cc9hiubmktbae6kghj